- Business
- AtkinsRéalis Group Inc. AtkinsRéalis Group Inc. is a Canadian professional services and project management company that provides engineering, procurement, construction, and end-to-end asset lifecycle solutions including consulting, design, advisory, environmental services, intelligent networks, cybersecurity, operations, maintenance, decommissioning, and capital investment services to clients in infrastructure, transportation, buildings, defense, mining, electrical power, nuclear, clean energy, water, and industrial sectors; these encompass mass transit and heavy rail systems, highways, bridges, airports, marine facilities, industrial and commercial buildings, greenfield and brownfield mining projects for commodities, fertilizers and sulphuric acid facilities, hydro, nuclear, renewables, thermal power generation, energy transmission and distribution, waste-to-energy systems, and desalination plants. Headquartered in Montreal, Quebec, the company was founded in 1911 through the establishment of its engineering predecessor and operates with approximately 37,000 employees across offices in over 50 countries and projects in more than 160 countries worldwide, serving public and private sector clients with a focus on sustainable infrastructure and energy transformation. Recent developments include the 2023 rebranding from SNC-Lavalin Group Inc. to leverage the Atkins legacy and emphasize realization of complex projects, the acquisition of a majority stake in U.S.-based David Evans Enterprises Inc. in a $300 million deal completed in 2025 to expand North American engineering capabilities in water, environment, and power sectors, a strategic partnership announced in 2025 with BWT Alpine Formula One Team to collaborate on aerospace, defense, nuclear, and high-performance engineering initiatives including an engineering academy, a share repurchase agreement in 2025 with La Caisse de dépôt et placement du Québec reducing its holdings while optimizing capital structure post the Highway 407 ETR divestiture, and securing contracts such as design and procurement for a biopharmaceutical facility in South Korea.